CAT and hepatocellular carcinoma: Relatively high NQO1 and low catalase expression in various HCC patients and cell lines indicates a potent therapeutic window in liver carcinoma for β-lap, and our above data confirmed that β-lap efficiently represses tumor cell growth in vitro.